Wat wij financieren (alleen in het Engels)

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

TrueNTH Global Registry

Movember Funding to Date

Global funding AUD equivalent 18,178,871

What we seek to achieve

Established in 2017 and operating across 17 countries, the TrueNTH Global Registry is an international project that aims to improve the physical and mental health of men with prostate cancer. Clinicians and hospitals contributing data to TrueNTH Global Registry receive regular, risk-adjusted reports on their patients’ health outcomes as compared to other clinicians and hospitals globally. This will support improvement in clinical practice and patient outcomes over time.

Country
Australia
Co-funded
Distinguished Gentlemen's Ride AUD 2,760,854
Implemented by
Movember
Project start date
January 2017
Project Status
In Progress

About the project

The TrueNTH Global Registry (TNGR) collects data on the diagnosis, treatment, disease progression, quality-of-life, survival and disease progression of patients living with prostate cancer. A significant focus of the TNGR is the collection patient-reported outcomes measures (PROMs), at diagnosis and also at 12 months following diagnosis.

PROMs collected include evaluations of urinary, bowel, and sexual dysfunction, and their impact on men living with prostate cancer. The collection of PROMs is a vital component of the registry, ensuring that the patient functional outcomes are linked directly to their clinical management.

The TNGR is the only global clinical quality registry for men diagnosed and living with prostate cancer. Analyses of the TNGR data enable the documentation of differences in care provided both between and within countries.

(Local investment AUD 3,932,321)

>
Page 1 of 31